A Novel 2-Metagene Signature to Identify High-Risk HNSCC Patients amongst Those Who Are Clinically at Intermediate Risk and Are Treated with PORT

SIMPLE SUMMARY: The aim of this matched-pair study including patients with locally advanced head and neck squamous cell carcinoma (HNSCC) was to identify patients who are biologically at high risk for the development of loco–regional recurrences after surgery and postoperative radiotherapy (PORT) bu...

Descripción completa

Detalles Bibliográficos
Autores principales: Patil, Shivaprasad, Linge, Annett, Hiepe, Hannah, Grosser, Marianne, Lohaus, Fabian, Gudziol, Volker, Kemper, Max, Nowak, Alexander, Haim, Dominik, Tinhofer, Inge, Budach, Volker, Guberina, Maja, Stuschke, Martin, Balermpas, Panagiotis, von der Grün, Jens, Schäfer, Henning, Grosu, Anca-Ligia, Abdollahi, Amir, Debus, Jürgen, Ganswindt, Ute, Belka, Claus, Pigorsch, Steffi, Combs, Stephanie E., Boeke, Simon, Zips, Daniel, Jöhrens, Korinna, Baretton, Gustavo B., Baumann, Michael, Krause, Mechthild, Löck, Steffen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221048/
https://www.ncbi.nlm.nih.gov/pubmed/35740697
http://dx.doi.org/10.3390/cancers14123031

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221048/
https://www.ncbi.nlm.nih.gov/pubmed/35740697
http://dx.doi.org/10.3390/cancers14123031

Ejemplares similares